Form 4: Intuitive Surgical SVP Mark Brosius Sells Shares Under 10b5-1 Trading Plan

Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, sold a total of 588 shares of common stock between March 5th and March 7th, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Mark Brosius, a Senior Vice President at Intuitive Surgical, executed multiple sales of Intuitive Surgical common stock.
• The transactions occurred between March 5, 2024, and March 7, 2024.
• A total of 588 shares were sold.
• The sales were conducted under a pre-arranged trading plan that complies with SEC Rule 10b5-1.
• The trading plan is set to expire on June 7, 2024.
• The prices per share varied, with sales at $400, $386.76, and $393.3.
• Following these transactions, Brosius directly owns 1,450 shares of Intuitive Surgical common stock.

Sentiment

Score: 5

Explanation: The document is neutral in sentiment as it simply reports stock sales under a pre-existing trading plan. It doesn't inherently indicate positive or negative performance for the company.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies and are often part of a pre-planned diversification strategy or to cover personal expenses. The use of 10b5-1 trading plans allows insiders to sell shares without being accused of trading on non-public information.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders due to the slight dilution of shares.
• The sales are unlikely to have a significant impact on employees, customers, suppliers, or creditors.

Key Dates